EGFR and colorectal carcinoma: Current therapeutic strategies for CRC include irinotecan, oxaliplatin, fluoropyrimidines (5-fluorouracil and capecitabine), EGFR antibodies (cetuximab and panitumumab), and VEGF antibodies (bevacizumab and ziv-aflibercept) [2].